We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCyanconnode Regulatory News (CYAN)

Share Price Information for Cyanconnode (CYAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.40
Bid: 8.20
Ask: 8.60
Change: -0.25 (-2.89%)
Spread: 0.40 (4.878%)
Open: 8.65
High: 8.65
Low: 8.40
Prev. Close: 8.65
CYAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Options

7 Jul 2016 07:00

RNS Number : 4807D
Cyan Holdings Plc
07 July 2016
 

Cyan Holdings plc

("CyanConnode" or the "Group")

Issue of Options

CyanConnode (AIM:CYAN.L), the world leader in narrowband RF mesh networks for Omni Internet of Things communications, announces that it has awarded options to acquire ordinary shares of 0.01 pence per share in the Group ("Options") to John Cronin, Executive Chairman, to Simon Smith, Chief Financial Officer, and to Harry Berry, Non-Executive Director and to certain other employees of the Group, including Connode employees following the completion of the acquisition of Connode as announced on 1 July 2016, as follows:

Name

Position

Current number of Options held

Exercise Price of current Options (in pence per share)

Number of new Options granted

Exercise price (in pence per share)

Total number of Options now held

Per cent. of current issued share capital

John Cronin

Executive Chairman

76,560,756 101,689,440

0.3 0.42

387,580,509

0.25

565,764,961

4.00%

 

 

178,250,196

 

 

 

 

 

 

 

 

 

 

 

 

 

Simon Smith

Chief Financial Officer

42,006,335 26,149,218

0.3 0.42

148,249,545

0.25

216,405,098

1.53%

 

 

68,155,553

 

 

 

 

 

 

 

 

 

 

 

 

 

Harry Berry

Non-Executive Director

5,000,000 7,000,000 22,320,884

 0.38 0.29 0.28

74,588,871

0.25

108,909,755

0.77%

 

 

34,320,884

 

 

 

 

 

 

 

 

 

 

 

 

 

The Options for all three directors are exercisable as to 33 per cent. of the issued amount from 1 July 2017 and 33 per cent. of the issued amount on 1 July for each of the following two years.

The Options will lapse if unexercised after 10 years from the date of grant. The Options have been issued at an exercise price of 0.25 pence per share, which represents a 39 per cent. premium to the Placing price of 0.18 pence approved by shareholders at the General Meeting held on 30 June 2016 and a premium of 40.8 per cent. to the closing market price on 6 July 2016, being the day before the options were issued. The Options already held by all three directors are at significant premiums to the current share price and can be seen in the table above.

The Options listed above are the only share options currently held by each of John Cronin, Simon Smith and Harry Berry, and represent a total of 6.3 per cent. of the issued share capital following admission to AIM on 1 July 2016 of the 7,026,259,138 new ordinary shares issued pursuant to the Placing announced on 14 June 2016 (the "current issued share capital").

In addition to the Options, the directors above have the following interests in ordinary shares in the company:

 

 

 

Name

Amount invested to date (£)

Amount to be invested via salary sacrifice from July 2016 to June 2017 (£)

Total invested/to be invested through to July 2017 (£)

No of ordinary shares in July 2017

Percentage of current issued share capital

John Cronin

417,290

374,009

791,299

386,135,926

2.73%

Simon Smith

352,677

152,920

505,597

210,833,244

1.49%

Harry Berry

113,600

89,009

202,609

95,330,380

0.67%

TOTAL

883,567

615,938

1,499,505

692,299,550

4.89%

Following the above grants, the total number of ordinary shares under option represents 13.5 per cent. of the current issued share capital of the Group.

Enquiries:

Cyan Holdings plc

www.cyantechnology.com

John Cronin, Executive Chairman

 

Tel: +44 (0) 1954 234 400

Cantor Fitzgerald Europe

NOMAD and Joint Broker

 

Andrew Craig / Richard Salmond

 

Beaufort Securities Limited

Joint Broker

Jon Belliss

 

Tel: +44 (0) 20 7894 7000

 

 

 

Tel: +44 (0) 20 7382 8300

Walbrook PR

(Investor Relations)

 

Paul Cornelius / Nick Rome

Tel: +44(0) 20 7933 8780

cyanconnode@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSSSFAMFMSEIW
Date   Source Headline
18th Apr 20247:00 amRNSAppointment of Joint Broker
17th Apr 20241:56 pmRNSHolding(s) in Company
16th Apr 20247:00 amRNSTrading Update
15th Apr 20247:00 amRNSOrder For A New Deployment In India
12th Apr 20247:00 amRNSMiddle East Energy Leadership Summit 2024
15th Jan 20247:00 amRNSAppointment of Non-Executive Director
11th Jan 20247:00 amRNSOrder For One Million Omnimesh Modules
27th Dec 20234:18 pmRNSDirector Dealing
19th Dec 20237:00 amRNSInterim Results
6th Dec 20231:32 pmRNSChange of Registered Office
1st Dec 20234:18 pmRNSHolding(s) in Company
21st Nov 20232:31 pmRNSHolding(s) in Company
20th Nov 20236:14 pmRNSIssue of Share Options – Correction
20th Nov 20237:00 amRNSNamed as One of the Fastest Growing Companies
17th Nov 20233:45 pmRNSDirector Option Grants
17th Nov 20238:30 amRNSHolding(s) in Company
16th Nov 202312:48 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSRanked 2nd Fastest-Growing UK Company in India
13th Nov 20236:11 pmRNSPlacing and Subscription – update
9th Nov 20238:02 amRNSResult of Oversubscribed Placing and Subscription
8th Nov 20235:24 pmRNSProposed Placing and Subscription to Raise c.£2.5m
31st Oct 20237:15 amRNSContract in the Middle East and North Africa
10th Oct 20237:00 amRNSOrder for 300,000 Omnimesh Modules
5th Oct 20237:00 amRNSTrading Update
24th Aug 202312:18 pmRNSResult of AGM
17th Aug 20231:00 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNS2023 Annual General Meeting
4th Aug 20235:34 pmRNSDirector Dealing
2nd Aug 20237:00 amRNSOrder for 300,000 Omnimesh Modules
26th Jul 20235:34 pmRNSCorrection: Final Results
26th Jul 20237:00 amRNSFinal Results
25th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jul 20237:00 amRNSTrading Update
22nd Jun 20237:00 amRNSCyanConnode India is a Start-Up 50 Trailblazer
25th May 20238:10 amRNSOrder for 600,000 Omnimesh Modules
9th May 20233:45 pmRNSHolding(s) in Company
17th Apr 20237:00 amRNSInterview with MD & CEO for CyanConnode India
3rd Apr 20237:00 amRNSCyanConnode and Alfanar Sign MOU for AMI projects
21st Mar 20237:15 amRNSHardman Research - Acceleration and revenue uplift
13th Mar 20237:00 amRNSCyanConnode Banking Arrangements
7th Mar 20237:00 amRNSCollaboration with Silicon Laboratories
6th Mar 20237:00 amRNSAppointment of Nominated and Financial Adviser
6th Feb 20238:51 amRNSStrategic Framework Agreement - Replacement
6th Feb 20238:21 amRNSStrategic Framework Agreement
6th Feb 20237:00 amRNSStrategic Framework Agreement
31st Jan 20237:00 amRNSHolding(s) in Company
24th Jan 20238:00 amRNSResult of Oversubscribed Placing and Subscription
23rd Jan 20235:11 pmRNSProposed Placing and Subscription
19th Jan 20237:00 amRNSChange of Adviser
4th Jan 20237:00 amRNSOrder From New Partner

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.